Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The European Prevention of Alzheimer’s Dementia (EPAD study) aims to address the urgent need for new treatments designed to prevent Alzheimer’s Dementia. The main study objectives are to: 1. Learn and understand better the factors involved in developing Alzheimer’s dementia. 2. To develop new treatments more quickly which are hoped to prevent Alzheimer’s dementia.

We are looking for

People aged 50 or over who have no dementia diagnosis (you may have a diagnosis of mild cognitive impairment or no diagnosis at all). You must be willing to consider taking part in drug trials in future, willing to travel to the Warneford Hospital for annual study assessments involving cognitive tasks, MRI scans and research samples and have a study partner (a relative or friend who could accompany you to study visits)


You will be compensated for your travel to the Warneford Hospital.